Literature DB >> 2499461

Monocyte C1-inhibitor synthesis in patients with C1-inhibitor deficiency.

D F Lappin1, A R McPhaden, P L Yap, P E Carter, G D Birnie, J E Fothergill, K Whaley.   

Abstract

Monocytes of seven out of eight patients with type 1 C1-inhibitor (C1-inh) deficiency (HAE) produced 40% as much C1-inh as monocytes from normal donors (controls). In contrast, monocytes from three patients with type 2 and three patients with acquired C1-inh deficiency produced similar amounts of C1-inh as controls. Recombinant gamma-interferon (gamma-interferon 10 ng/ml) stimulated C1-inh production of C1-inh (eight-10-fold) by control and patients' monocytes. Monocytes from patients with type 1 HAE contained 40% the level of C1-inh messenger ribonucleic acid (mRNA) found in control monocytes. Gamma-interferon increased the abundance of C1-inh mRNA by the same extent in both control and patients' monocytes. C1-inh protein and mRNA were undetectable in the monocytes of one patient, unless stimulated by gamma-interferon. Under these conditions, his monocytes produced comparable amounts of C1-inh (protein and mRNA) as gamma-interferon-stimulated monocytes of the other type 1 HAE patients. The data suggest that in most type 2 HAE patients there is a lesion in the C1-inh gene such that mRNA is transcribed by a single allele.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499461     DOI: 10.1111/j.1365-2362.1989.tb00194.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

Review 1.  HAE Pathophysiology and Underlying Mechanisms.

Authors:  Bruce L Zuraw; Sandra C Christiansen
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

2.  Complement biosynthesis in human synovial tissue.

Authors:  G J Moffat; D Lappin; G D Birnie; K Whaley
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

3.  Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema.

Authors:  D Frangi; M Cicardi; A Sica; F Colotta; A Agostoni; A E Davis
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

4.  Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema.

Authors:  J Kramer; Y Katz; F S Rosen; A E Davis; R C Strunk
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

5.  Cell surface expression and function of the macromolecular c1 complex on the surface of human monocytes.

Authors:  Kinga K Hosszu; Alisa Valentino; Yan Ji; Mara Matkovic; Lina Pednekar; Nina Rehage; Nithin Tumma; Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Front Immunol       Date:  2012-03-05       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.